Skip to main content

Day: July 23, 2021

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek® business from Otsuka America Pharmaceutical, Inc. for $20 million in cash. The transaction is expected to close in Meridian’s fiscal fourth quarter. With this acquisition, Meridian will assume the customer relationships in North America to supply BreathTek®, a urea breath test for the detection of Helicobacter pylori. The acquisition is expected to add more than $20 million of annual revenue, strengthening Meridian’s position as a leading provider of gastrointestinal diagnostic solutions, and is expected to be accretive to earnings and cash immediately. Jack Kenny, Chief Executive...

Continue reading

Safe Bulkers, Inc. Sets Date for Second Quarter 2021 Results, Conference Call and Webcast

Earnings Release: Wednesday, July 28, 2021, After Market Closes Conference Call and Webcast: Thursday, July 29, 2021, at 9:30 A.M. Eastern Time MONACO, July 23, 2021 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it will release its results for the quarter ended June 30, 2021 after the market closes in New York on Wednesday, July 28, 2021. On Thursday, July 29, 2021, at 9:30 A.M. Eastern Time, the Company’s management team will host a conference call to discuss the financial results. Conference Call Details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1(877) 553-9962 (US Toll Free Dial In), 0(808) 238-0669 (UK Toll Free Dial In) or +44 (0) 2071 928592 (Standard International...

Continue reading

Licensed Cannabis and Hemp Producer One World Pharma Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services

GARDEN CITY, N.Y., July 23, 2021 (GLOBE NEWSWIRE) — One World Pharma (OTC: OWPC) (“One World” or the “Company”), a fully licensed cannabis and hemp producer in Colombia, today announces that it has retained CORE IR, a leading investor relations, public relations and strategic advisory firm, to assist the Company with investor relations, public relations and shareholder communications services. CORE IR will focus on expanding market awareness for One World, conveying the company’s business model and growth strategies to the institutional and retail investment communities. CORE IR, a boutique Investor and Public Relations and strategic advisory firm, specializes in leveraging the most effective investment, growth and exposure strategies for small to mid-sized publicly traded and privately-held companies through an integrated...

Continue reading

Allegiance Bancshares, Inc. Declares Common Stock Dividends

HOUSTON, Tx., July 23, 2021 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, announced the Board of Directors of Allegiance declared a cash dividend of $0.12 per share to be paid on September 15, 2021 to shareholders of record as of August 31, 2021. About Allegiance Bancshares, Inc. As of March 31, 2021, Allegiance was a $6.43 billion asset Houston, Texas-based bank holding company. Through its wholly owned subsidiary, Allegiance Bank, Allegiance provides a diversified range of commercial banking services primarily to small- to medium-sized businesses and individual customers in the Houston region. Allegiance’s super-community banking strategy was designed to foster strong customer relationships while benefiting from a platform and scale that is competitive with...

Continue reading

1ST Constitution Bancorp Reports a 39.6% Increase in Net Income for the Second Quarter of 2021 and Declares a Quarterly Dividend of $0.10 Per Share

CRANBURY, N.J., July 23, 2021 (GLOBE NEWSWIRE) — 1ST Constitution Bancorp (NASDAQ: FCCY), the holding company (the “Company”) for 1ST Constitution Bank (the “Bank”), today reported net income of $5.2 million and diluted earnings per share of $0.50 for the three months ended June 30, 2021 compared to net income of $3.7 million and diluted earnings per share of $0.36 for the three months ended June 30, 2020. Net income increased 39.6% and diluted earnings per share increased 38.9% for the second quarter of 2021 compared to the second quarter of 2020. On July 11, 2021, the Company and Lakeland Bancorp, Inc. (NASDAQ: LBAI), the holding company (“Lakeland”) for Lakeland Bank, entered into an Agreement and Plan of Merger, pursuant to which the Company will merge with and into Lakeland, with Lakeland continuing as the surviving entity...

Continue reading

Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures

Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents Plantation, Florida , July 23, 2021 (GLOBE NEWSWIRE) — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that they have filed a new provisional patent to protect their intellectual property surrounding their development of nerve agent counter measures. “We originally announced this project in early 2018,” stated Rik J Deitsch, Chief Executive...

Continue reading

Mueller Water Products Announces Dates for Third Quarter 2021 Earnings Release and Conference Call

ATLANTA, July 23, 2021 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its third quarter ended June 30, 2021, after U.S. markets close on Wednesday, August 4, 2021. On Thursday, August 5, 2021, at 11:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call. About Mueller Water Products, Inc. Mueller Water Products, Inc. (“Mueller”) is a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America. Our broad product and service...

Continue reading

Invesco Ltd: Restore Plc

Opening Position Disclosure FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Restore Plc.  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest...

Continue reading

Notification about acquisition of voting rights of Invalda INVL

Invalda INVL provides received notification from UAB Lucrum investicija on acquisition of voting rights. Date of threshold – 21 July 2021Declared threshold – 25% (only in respect of directly held shares; the votes held by the group do not change) The person authorised to provide additional information:Darius ŠulnisPresident of Invalda INVLE-mail darius.sulnis@invl.com  AttachmentAcquisition of voting rights_Lucrum investicija_07 2021

Continue reading

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Asset purchase agreement to acquire all material operating assets of 5 addiction clinics Share purchase agreement to acquire 3 specialized pharmacies Share purchase agreement to acquire leading telehealth provider in addiction services Combined for over 35,000 patient visits over the past 12 months, 70% via telehealth Targets combined trailing twelve months revenues of approximately $7.5 million, with over $1 million in EBITDA Aggregate purchase price for the three acquisitions of approximately C$4 million in cash and C$1.5 million in stockVANCOUVER, British Columbia, July 23, 2021 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (“Levitee” or the “Company“), an integrative wellness company, is pleased to announce that it has executed the following definitive agreements (collectively, the “Agreements“):Asset...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.